Ligand Pharmaceuticals
LGND • NASDAQ
Ligand Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Todd C. Davis, with a market cap of $4.5B.
Market Cap$4.5B
Employees58.0
CEOTodd C. Davis
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Ligand Pharmaceuticals FAQ
Common questions about Ligand Pharmaceuticals
Ligand Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 14, 2026 before market open. Analysts estimate revenue of $59.1M.
Ligand Pharmaceuticals has approximately 58 employees.